☆ 4.4 Letter

Omacetaxine mepesuccinate for patients with accelerated phase chronic myeloid leukemia with resistance or intolerance to two or more tyrosine kinase inhibitors

HAEMATOLOGICA (2013)

Get Full Text
Add to Collection

Journal

HAEMATOLOGICA
Volume 98, Issue 7, Pages E78-E79

Publisher

FERRATA STORTI FOUNDATION
DOI: 10.3324/haematol.2012.083006

Keywords

omacetaxine; homoharringtonine; advanced chronic myeloid leukemia; tyrosine kinase inhibitors; imatinib; dasatinib; nilotinib

Categories

Hematology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.